NU610 · Unit 9

NU610 Unit 9 incidental finding analysis example

NP III Clinical - Primary Care Focus Purdue University Global Free custom sample in 24 to 48h

A CT scan ordered to look for one thing often finds another, and the NU610 incidental finding analysis usually asks what the second finding deserves. This analysis concerns a composite [43]-year-old man, a lifelong nonsmoker, whose emergency CT for suspected pulmonary embolism came back negative but reported a [7 mm] solid nodule in the right upper lobe.

What this page holds

An NU610 Unit 9 analysis of one incidental [7 mm] lung nodule in a composite nonsmoker, setting its follow-up by the Fleischner criteria and closing the loop an emergency visit opened. Searches like "nu 610 unit 9 assignment example", "nu610 unit 9 sample" and "nu610 unit 9 example" land here.

What a finished NU610 Unit 9 incidental finding analysis looks like

Three pages in four parts. Part one restates the finding exactly as reported, quotes the radiologist's recommendation, and gives the context: a negative CT pulmonary angiogram, no cancer history, no smoking, no occupational exposure, no family history of lung cancer. Part two assigns low risk by the Fleischner factors, noting upper-lobe location as the one feature that raises concern. Part three applies the 2017 Fleischner guidelines for a single solid nodule of 6 to 8 mm in a low-risk patient: CT at 6 to 12 months, then consideration of CT at 18 to 24 months. PET, biopsy and immediate referral are set aside at this size. Part four is the follow-up plan: the patient informed, a CT booked for [month and year], and a tracking entry that flags an unperformed scan.

How a NU610 Unit 9 example is structured

The analysis opens with the finding in the radiologist's own words, because interpretation begins with what was actually reported. Context follows, organized as the risk factors the guideline uses: age, smoking, exposures, family history, nodule size, morphology and location. The risk assignment section weighs those factors and admits the one that points upward. Its key observation is that the low-risk and high-risk schedules share the same first step for a nodule of this size, so the immediate decision does not hinge on the classification. Next, the Fleischner recommendation is quoted along with its exclusions, including patients under 35 and lung cancer screening populations, to show that the guideline applies here. A section on tests not ordered follows. The plan section names who told the patient, when the scan is due, and what the tracking step does if it is missed.

The radiologist's exact words

The radiologist's wording is reproduced exactly, including any recommendation. Paraphrasing a size or a description can change which guideline row applies, so the analysis works from the original text.

One risk factor pointing up

Upper-lobe location is a feature the risk models count against a nodule. The analysis names it rather than hiding it, then explains why the overall picture in a nonsmoker of [43] still reads as low risk.

A decision that survives the classification

For a single solid nodule of this size, the Fleischner low-risk and high-risk schedules both begin with CT at 6 to 12 months. The analysis points out that the first step is therefore settled either way.

No PET scan, no biopsy

PET imaging performs poorly on nodules this small, and biopsy is not proportionate at this risk. Both appear in the analysis under a considered-but-declined line, so the restraint is visible on the page.

The loop the emergency visit opened

The finding surfaced in an emergency department, but its follow-up belongs to primary care. The analysis records who informed the patient, the date the repeat scan is due, and the alert that fires if it is not done.

Where marks go in NU610 Unit 9

An analysis that repeats the radiology report and goes no further misses the two questions that matter: what the finding deserves, and who owns it now. Vague advice to correlate clinically, or a scan ordered at an interval that matches no guideline row, costs almost as much. Risk factors left unassessed draw a deduction, since the schedule depends on them, and so does PET or biopsy proposed for a nodule the guideline would simply watch. An analysis that applies Fleischner criteria to a patient the guideline excludes is marked as a misapplication. Plans that set a date but no tracking step leave the finding exactly where incidental findings are usually lost. Minor deductions go to a size misquoted from the report, and to patient communication described only as done.

Get a NU610 Unit 9 example written to your instructions

Paste the Unit 9 finding exactly as your NU610 case reports it, along with the patient context and the rubric. An analysis written from those returns within 24-48h, at no charge on a first request, quoting the report, weighing each risk factor the relevant guideline uses, choosing the matching follow-up row, and naming who owns the loop from here.

NU610 Unit 9 questions, answered

Which guideline applies to an incidental finding?

The one written for that organ and that type of finding: Fleischner for incidental lung nodules in adults, the ACR incidental findings white papers for many abdominal findings, and thyroid-specific systems for thyroid nodules. Check each guideline's stated exclusions before applying it, since a screening population or a patient with known cancer usually falls outside it.

Should the analysis follow the radiologist's recommendation?

Usually, if it matches the guideline. Where it differs, name both, explain the discrepancy, and say which one the plan adopts. Radiologists sometimes recommend follow-up that is more or less intensive than the guideline for reasons visible in the images, so a phone call or an addendum request can be part of a good plan.

Who is responsible for following up a finding from an emergency visit?

In most systems, the primary care clinician who receives the report, unless the emergency team explicitly arranged follow-up. The analysis should say who told the patient and who holds the tracking task. Findings discovered in one setting and owned in another are a classic source of missed follow-up, which is why graders look for named ownership.